// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A. Weissenbacher - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

Y. Marie - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

vasopressin Injection

K. Soliman - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Coronary Artery Disease

N/A

A. Mekhaimar - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

J. Gopal - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

H. Mergental - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

J. A. Attard - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A. Cherukuri - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal allograft rejection

Interleukin-10

D. Christiadi - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Focal segmental glomerulosclerosis

Alemtuzumab

P. Husen - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Delayed graft function

N/A

S. O'Neill - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

P. N. Harden - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Mycophenolate mofetil

N. Vallant - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

End stage renal disease

N/A

N. Phagura - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Post-transplant diabetes mellitus

Mycophenolate mofetil

C. Garcia-Sanchez - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Graft-versus-host disease

N/A

J. T. Langford - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Ischemia-reperfusion injury

Fibrinogen (IV)

H. Hendra - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

H. Bheemreddy - American Transplant Congress (ATC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Post-transplant lymphoproliferative disorder

Oraprine